Notably, TT levels were not associated with NAFLD in any model, including a model with VAT and HOMA-IR (OR, 0.93; 95% CI, 0.63–1.36) (Table 2), and even in a model excluding SHBG (OR, 0.74; 95% CI, 0.52–1.04) (Table 3). This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.